• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection.

作者信息

Kondili Loreta A, Craxì Lucia, Andreoni Massimo, Mennini Francesco S, Razavi Homie

机构信息

Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.

Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Palermo, Italy.

出版信息

Liver Int. 2022 May;42(5):960-962. doi: 10.1111/liv.15243.

DOI:10.1111/liv.15243
PMID:35447008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9115188/
Abstract
摘要

相似文献

1
Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection.丙型肝炎病毒（HCV）与新冠病毒病（COVID-19）相关服务的机会性联合筛查：一种需要深入思考的创新性应对措施。
Liver Int. 2022 May;42(5):960-962. doi: 10.1111/liv.15243.
2
The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.在采用乙肝病毒（HBV）、丙肝病毒（HCV）和艾滋病毒（HIV）免疫测定法进行筛查的土耳其献血者中重复检测的意义，以及S/CO比值在丙肝病毒/艾滋病毒筛查检测结果解读中以及作为进一步确证检测决定因素的重要性。
Transfus Med. 2010 Jun;20(3):152-9. doi: 10.1111/j.1365-3148.2009.00987.x. Epub 2010 Jan 5.
3
Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.在英格兰东南部农村地区接受治疗的吸毒者中筛查艾滋病毒、乙肝病毒和丙肝病毒标志物。
J Public Health Med. 2000 Dec;22(4):531-9. doi: 10.1093/pubmed/22.4.531.
4
HIV and Hepatitis C Virus Screening in the Emergency Department and Linkage to Care During COVID-19: Challenges and Solutions.急诊科中的艾滋病毒和丙型肝炎病毒筛查以及 COVID-19 期间的护理衔接：挑战与解决方案
J Acquir Immune Defic Syndr. 2021 Oct 1;88(2):e14-e16. doi: 10.1097/QAI.0000000000002763.
5
Will a quadruple multiplexed point-of-care screening strategy for HIV-related co-infections be feasible and impact detection of new co-infections in at-risk populations? Results from cross-sectional studies.一种用于艾滋病毒相关合并感染的四重多重即时检验筛查策略是否可行，对高危人群中新合并感染的检测是否有影响？横断面研究结果。
BMJ Open. 2014 Dec 15;4(12):e005040. doi: 10.1136/bmjopen-2014-005040.
6
Barriers to Hepatitis C Screening in a Minority Population: A Comparison of Hepatitis C and Human Immunodeficiency Virus Screening Rates at a Community STD Clinic in Miami, Florida.迈阿密佛罗里达州社区 STD 诊所丙型肝炎和人类免疫缺陷病毒筛查率比较：少数民族人群丙型肝炎筛查障碍。
J Community Health. 2017 Oct;42(5):921-925. doi: 10.1007/s10900-017-0335-6.
7
Coalition seeks funding for HCV/HIV co-infection. Integrating services makes economic, medical sense.联盟寻求为丙型肝炎病毒/艾滋病病毒合并感染提供资金。整合服务具有经济和医学意义。
AIDS Alert. 2003 May;18(5):63-5.
8
Implementation of a Collaborative HIV and Hepatitis C Screening Program in Appalachian Urgent Care Settings.在阿巴拉契亚紧急护理环境中实施合作性 HIV 和丙型肝炎筛查计划。
West J Emerg Med. 2018 Nov;19(6):1057-1064. doi: 10.5811/westjem.2018.9.39512. Epub 2018 Oct 9.
9
2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.2014 年法国乙型肝炎和丙型肝炎筛查指南：一种针对慢性病毒（即 HBV、HCV 和 HIV）的靶向和大规模联合检测策略。
Liver Int. 2016 Oct;36(10):1442-9. doi: 10.1111/liv.13135. Epub 2016 May 1.
10
Identifying ED patients with previous abnormal HIV or hepatitis C test results who may require additional services.识别出有既往异常 HIV 或丙型肝炎检测结果的 ED 患者，这些患者可能需要额外的服务。
Am J Emerg Med. 2020 Sep;38(9):1831-1833. doi: 10.1016/j.ajem.2020.05.020. Epub 2020 May 11.

引用本文的文献

1
Low prevalence of current and past SARS-CoV-2 infections among visitors and staff members of homelessness services in Amsterdam at the end of the second wave of infections in the Netherlands.在荷兰第二波感染结束时，阿姆斯特丹无家可归者服务机构的访客和工作人员中，当前和过去 SARS-CoV-2 感染的患病率较低。
PLoS One. 2023 Jul 25;18(7):e0288610. doi: 10.1371/journal.pone.0288610. eCollection 2023.
2
Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain.西班牙对边缘化人群开展的新冠病毒疫苗接种与丙型肝炎病毒筛查联合干预措施
Commun Med (Lond). 2023 May 12;3(1):66. doi: 10.1038/s43856-023-00292-y.
3
Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions.意大利南部消除丙型肝炎：不同医院科室住院患者 HCV 筛查和护理衔接模型。
Viruses. 2022 May 19;14(5):1096. doi: 10.3390/v14051096.

本文引用的文献

1
Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of southern Italy in the province of Salerno.在进行2019冠状病毒病检测或疫苗接种期间的丙型肝炎筛查。意大利南部萨勒诺省一个地区的经验。
Liver Int. 2022 Jun;42(6):1467-1469. doi: 10.1111/liv.15273. Epub 2022 Apr 23.
2
Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination.在接种 COVID-19 疫苗的 1969-1989 年出生队列中实施 HCV 筛查。
Liver Int. 2022 May;42(5):1012-1016. doi: 10.1111/liv.15216. Epub 2022 Mar 12.
3
A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions.通过传播途径和纤维化进展建立数学模型，以估计意大利不同地区未确诊的 HCV 个体。
BMC Infect Dis. 2022 Jan 17;22(1):58. doi: 10.1186/s12879-022-07042-w.
4
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis.意大利通过筛查诊断的患者接受抗 HCV 治疗的经济后果：一项前瞻性建模分析。
Appl Health Econ Health Policy. 2022 Jan;20(1):133-143. doi: 10.1007/s40258-021-00677-x. Epub 2021 Oct 12.
5
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.意大利实现丙型肝炎病毒（HCV）消除的里程碑：从免费筛查到 HCV 自由国家的区域路线图。
Dig Liver Dis. 2022 Feb;54(2):237-242. doi: 10.1016/j.dld.2021.03.026. Epub 2021 Apr 27.
6
Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression.意大利未确诊丙型肝炎病毒感染个体的估计患病率：基于传播途径和纤维化进展的数学模型
Epidemics. 2021 Mar;34:100442. doi: 10.1016/j.epidem.2021.100442. Epub 2021 Feb 11.
7
Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements.消除丙型肝炎的绝对目标和国家卫生政策范式：预见未来的需求。
Liver Int. 2021 Apr;41(4):649-655. doi: 10.1111/liv.14796. Epub 2021 Feb 8.
8
Progress towards elimination goals for viral hepatitis.迈向消除病毒性肝炎目标的进展。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):533-542. doi: 10.1038/s41575-020-0332-6. Epub 2020 Jul 23.
9
Optimization of hepatitis C virus screening strategies by birth cohort in Italy.意大利基于出生队列对丙型肝炎病毒筛查策略的优化。
Liver Int. 2020 Jul;40(7):1545-1555. doi: 10.1111/liv.14408. Epub 2020 Apr 2.
10
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination.《丙型肝炎共识治疗流程：为消除目标而进行的标准化报告》。
Clin Infect Dis. 2019 Nov 27;69(12):2218-2227. doi: 10.1093/cid/ciz714.